|
1
|
Ferrer R, Martin-Loeches I, Phillips G,
Osborn TM, Townsend S, Dellinger RP, Artigas A, Schorr C and Levy
MM: Empiric antibiotic treatment reduces mortality in severe sepsis
and septic shock from the first hour: Results from a
guideline-based performance improvement program. Crit Care Med.
42:1749–1755. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bassetti M, Righi E, Ansaldi F, Merelli M,
Trucchi C, De Pascale G, Diaz-Martin A, Luzzati R, Rosin C, Lagunes
L, et al: A multicenter study of septic shock due to candidemia:
Outcomes and predictors of mortality. Intensive Care Med.
40:839–845. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bihari D, Prakash S and Bersten A:
Low-dose vasopressin in addition to noradrenaline may lead to
faster resolution of organ failure in patients with severe
sepsis/septic shock. Anaesth Intensive Care. 42:671–674.
2014.PubMed/NCBI
|
|
4
|
Greeneltch KM, Haudenschild CC, Keegan AD
and Shi Y: The opioid antagonist naltrexone blocks acute endotoxic
shock by inhibiting tumor necrosis factor-alpha production. Brain
Behav Immun. 18:476–484. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tidswell M and LaRosa SP: Toll-like
receptor-4 antagonist eritoran tetrasodium for severe sepsis.
Expert Rev Anti Infect Ther. 9:507–520. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bone RC, Balk RA, Cerra FB, Dellinger RP,
Fein AM, Knaus WA, Schein RM and Sibbald WJ;: The ACCP/SCCM
Consensus Conference Committee. American College of Chest
Physicians/Society of Critical Care Medicine: Definitions for
sepsis and organ failure and guidelines for the use of innovative
therapies in sepsis. Chest. 101:1644–1655. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rittirsch D, Flierl MA and Ward PA:
Harmful molecular mechanisms in sepsis. Nat Rev Immunol. 8:776–787.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hotchkiss RS and Nicholson DW: Apoptosis
and caspases regulate death and inflammation in sepsis. Nat Rev
Immunol. 6:813–822. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Solomkin JS, Jenkins MK, Nelson RD,
Chenoweth D and Simmons RL: Neutrophil dysfunction in sepsis. II.
Evidence for the role of complement activation products in cellular
deactivation. Surgery. 90:319–327. 1981.PubMed/NCBI
|
|
10
|
Witko-Sarsat V, Rieu P, Descamps-Latscha
B, Lesavre P and Halbwachs-Mecarelli L: Neutrophils: Molecules,
functions and pathophysiological aspects. Lab Invest. 80:617–653.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Luster AD: Chemokines - chemotactic
cytokines that mediate inflammation. N Engl J Med. 338:436–445.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu Z, Lei X, Li X, Cai JM, Gao F and Yang
YY: Toll-like receptors and radiation protection. Eur Rev Med
Pharmacol Sci. 22:31–39. 2018.PubMed/NCBI
|
|
13
|
Zhang Y, Lu Y, Ma L, Cao X, Xiao J, Chen
J, Jiao S, Gao Y, Liu C, Duan Z, et al: Activation of vascular
endothelial growth factor receptor-3 in macrophages restrains
TLR4-NF-κB signaling and protects against endotoxin shock.
Immunity. 40:501–514. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Castle NA: Aquaporins as targets for drug
discovery. Drug Discov Today. 10:485–493. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu WH, Liu ZB, Hou YF, Hong Q, Hu DL and
Shao ZM: Inhibition of autophagy enhances the cytotoxic effect of
PA-MSHA in breast cancer. BMC Cancer. 14:2732014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li T, Dong ZR, Guo ZY, Wang CH, Zhi XT,
Zhou JW, Li DK, Chen ZT, Chen ZQ and Hu SY: Mannose-mediated
inhibitory effects of PA-MSHA on invasion and metastasis of
hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway. Liver
Int. 35:1416–1429. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hou J, Liu Y, Liu Y and Shao Y: The MSHA
strain of Pseudomonas aeruginosa activated TLR pathway and
enhanced HIV-1 DNA vaccine immunoreactivity. PLoS One.
7:e477242012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang M, Luo F, Zhang Y, Wang L, Lin W,
Yang M, Hu D, Wu X and Chu Y: Pseudomonas aeruginosa
mannose-sensitive hemagglutinin promotes T-cell response via
toll-like receptor 4-mediated dendritic cells to slow tumor
progression in mice. J Pharmacol Exp Ther. 349:279–287. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu XF, Wang L, Qu Y, Zhong DW, Miao XY
and Yao HL: Effect of the PA-MSHA vaccine on septic serum-induced
inflammatory response. Mol Med Rep. 7:1350–1354. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wen H: Sepsis induced by cecal ligation
and puncture. Methods Mol Biol. 1031:117–124. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Buras JA, Holzmann B and Sitkovsky M:
Animal models of sepsis: Setting the stage. Nat Rev Drug Discov.
4:854–865. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wiersinga WJ: Current insights in sepsis:
From pathogenesis to new treatment targets. Curr Opin Crit Care.
17:480–486. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kumar H and Bot A: Innate immune
recognition mechanisms and translational opportunities. Int Rev
Immunol. 32:113–115. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kumar S, Ingle H, Prasad DV and Kumar H:
Recognition of bacterial infection by innate immune sensors. Crit
Rev Microbiol. 39:229–246. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bachar O, Adner M, Uddman R and Cardell
LO: Toll-like receptor stimulation induces airway
hyper-responsiveness to bradykinin, an effect mediated by JNK and
NF-kappa B signaling pathways. Eur J Immunol. 34:1196–1207. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Poltorak A, He X, Smirnova I, Liu MY, Van
Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, et al:
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations
in Tlr4 gene. Science. 282:2085–2088. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Park JS, Svetkauskaite D, He Q, Kim JY,
Strassheim D, Ishizaka A and Abraham E: Involvement of toll-like
receptors 2 and 4 in cellular activation by high mobility group box
1 protein. J Biol Chem. 279:7370–7377. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kerger BD, Thuett KA and Finley BL:
Evaluation of four α-diketones for toll-like receptor-4 (TLR-4)
activation in a human transfected cell line. Food Chem Toxicol.
74:117–119. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Daubeuf B, Mathison J, Spiller S, Hugues
S, Herren S, Ferlin W, Kosco-Vilbois M, Wagner H, Kirschning CJ,
Ulevitch R, et al: TLR4/MD-2 monoclonal antibody therapy affords
protection in experimental models of septic shock. J Immunol.
179:6107–6114. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Levy MM, Fink MP, Marshall JC, Abraham E,
Angus D, Cook D, Cohen J, Opal SM, Vincent JL and Ramsay G;:
International Sepsis Definitions Conference: 2001
SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions
conference. Intensive Care Med. 29:530–538. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mossman KL, Mian MF, Lauzon NM, Gyles CL,
Lichty B, Mackenzie R, Gill N and Ashkar AA: Cutting edge: FimH
adhesin of type 1 fimbriae is a novel TLR4 ligand. J Immunol.
181:6702–6706. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nakae H, Endo S, Yamada Y and Inada K:
Bound and soluble adhesion molecule and cytokine levels in patients
with severe burns. Burns. 26:139–144. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huang Q, Shao L, He M, Chen H, Liu D, Luo
Y and Dai Y: Inhibitory effects of sasanquasaponin on
over-expression of ICAM-1 and on enhancement of capillary
permeability induced by burns in rats. Burns. 31:637–642. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jersmann HP, Hii CS, Ferrante JV and
Ferrante A: Bacterial lipopolysaccharide and tumor necrosis factor
alpha synergistically increase expression of human endothelial
adhesion molecules through activation of NF-kappaB and p38
mitogen-activated protein kinase signaling pathways. Infect Immun.
69:1273–1279. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Thomson AJ, Greer MR, Young A, Boswell F,
Telfer JF, Cameron IT, Norman JE and Campbell S: Expression of
intercellular adhesion molecules ICAM-1 and ICAM-2 in human
endometrium: Regulation by interferon-gamma. Mol Hum Reprod.
5:64–70. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cook-Mills JM: VCAM-1 signals during
lymphocyte migration: Role of reactive oxygen species. Mol Immunol.
39:499–508. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lee IT, Shih RH, Lin CC, Chen JT and Yang
CM: Role of TLR4/NADPH oxidase/ROS-activated p38 MAPK in VCAM-1
expression induced by lipopolysaccharide in human renal mesangial
cells. Cell Commun Signal. 10:332012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cho RL, Yang CC, Lee IT, Lin CC, Chi PL,
Hsiao LD and Yang CM: Lipopolysaccharide induces ICAM-1 expression
via a c-Src/NADPH oxidase/ROS-dependent NF-κB pathway in human
pulmonary alveolar epithelial cells. Am J Physiol Lung Cell Mol
Physiol. 310:L639–L657. 2016. View Article : Google Scholar : PubMed/NCBI
|
